Sapphire Star Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$3.47M Sell
17,840
-586
-3% -$114K 4.65% 2
2018
Q3
$3.82M Sell
18,426
-2,149
-10% -$424K 3.83% 2
2018
Q2
$3.8M Buy
20,575
+200
+1% +$35.4K 3.92% 2
2018
Q1
$3.47M Sell
20,375
-1,348
-6% -$247K 3.84% 2
2017
Q4
$3.78M Sell
21,723
-7,100
-25% -$1.26M 4.48% 2
2017
Q3
$5.37M Sell
28,823
-10,677
-27% -$1.89M 6.95% 2
2017
Q2
$6.8M Sell
39,500
-1,000
-2% -$163K 8.61% 2
2017
Q1
$6.64M Sell
40,500
-3,101
-7% -$515K 7.57% 2
2016
Q4
$6.43M Sell
43,601
-2,304
-5% -$347K 7.15% 2
2016
Q3
$7.66M Buy
45,905
+45,459
+10,193% +$7.69M 9.24% 1
2016
Q2
$68K Sell
446
-40,458
-99% -$6.29M 0.09% 64
2016
Q1
$6.64M Hold
40,904
5.26% 7
2015
Q4
$6.64M Buy
+40,904
New +$6.43M 8.79% 1

Other funds holding AMGN

Sapphire Star Partners's AMGN Position: Q4 2018 in Review

Sapphire Star Partners reduced its Amgen (AMGN) stake by 3.2% in Q4 2018, selling an estimated $114K and leaving 17,840 shares worth $3.47M. The position accounts for 4.65% of the portfolio, ranked #2.

Sapphire Star Partners first reported a position in AMGN in Q4 2015 and has held it in 13 quarters since. The position peaked at $7.66M in Q3 2016. 1,892 funds tracked by Wall St. Rank hold AMGN as of Q4 2018.

  • Sapphire Star Partners held 17,840 shares of Amgen worth $3.47M as of Q4 2018.
  • Sapphire Star Partners sold 586 Amgen shares in Q4 2018, an estimated $114K.
  • Amgen made up 4.65% of Sapphire Star Partners's portfolio in Q4 2018, its #2 holding.
  • Sapphire Star Partners first reported a position in Amgen in Q4 2015 and has held it in 13 quarters since.
  • Sapphire Star Partners's Amgen position peaked at $7.66M in Q3 2016.
  • 1,892 funds tracked by Wall St. Rank held Amgen as of Q4 2018.

Based on Sapphire Star Partners's 13F filing for Q4 2018, filed 12 Feb 2019.